3-(3-Chlorophenyl)-N-(2-(thiazol-4-yl)-1H-benzo[d]imidazol-6-yl)butanamide

Catalog No. :
ACBCGW225
CAS No. :
689297-68-5
Molecular Formula :
C20H17ClN4OS
Molecular Weight :
396.90

IUPAC Name:KV2 channel inhibitor-1

3-(3-Chlorophenyl)-N-(2-(thiazol-4-yl)-1H-benzo[d]imidazol-6-yl)butanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$76.00Login to see priceInquiryInquiry
5mg98%$186.00Login to see priceInquiryInquiry
10mg98%$309.00Login to see priceInquiryInquiry
25mg98%$519.00Login to see priceInquiryInquiry
50mg98%$740.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(3-Chlorophenyl)-N-(2-(thiazol-4-yl)-1H-benzo[d]imidazol-6-yl)butanamide
IUPAC NameKV2 channel inhibitor-1
Molecular FormulaC20H17ClN4OS
Molecular Weight396.90
SMILESO=C(NC1=CC=C2N=C(C3=CSC=N3)NC2=C1)CC(C)C4=CC=CC(Cl)=C4
InChI KeyMRQZOINSVKHDQS-UHFFFAOYSA-N
SynonymDTXSID701141042 | 3-Chloro-beta-methyl-N-[2-(4-thiazolyl)-1H-benzimidazol-6-yl]benzenepropanamide | EX-A4833 | Kv2-IN-A1 | CS-0103554 | Benzenepropanamide, 3-chloro-beta-methyl-N-[2-(4-thiazolyl)-1H-benzimidazol-6-yl]- | 3-(3-chlorophenyl)-N-[2-(1,3-thiaz
CAS No.689297-68-5
PubChem CID10023694

Synthetic Route by SureRoute

1. ACBCGW225 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEXRS031 route compound structure diagram
    ACEXRS03125893-06-5 In Stock
  4. Then
  5. ACBCGW225 route product structure diagram
    ACBCGW225689297-68-5
Inquiry

2. ACBCGW225 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEXRS031 route compound structure diagram
    ACEXRS03125893-06-5 In Stock
  4. Then
  5. ACBCGW225 route product structure diagram
    ACBCGW225689297-68-5
Inquiry

Comments (0)